This clinical trial is for patients with head and neck squamous cell cancer (HNSCC) receiving treatment with cisplatin, a type of chemotherapy, and/or radiation. Both treatments can sometimes cause hearing loss. The study aims to see if offering hearing tests, called audiometry, closer to home or remotely encourages more patients to check for hearing loss. Audiometry measures the quietest sounds you can hear at different pitches. Identifying any hearing loss early can help adjust treatments to prevent further damage. Patients will be divided into two groups: some will have their hearing tested at a hospital, while others, living far away or having advanced cancer, will get tests closer to home or remotely. The study includes adults 18 and older who can consent and have specific types of head and neck cancer.
- The study lasts for about 12 months, with hearing tests at the start, 3 months, and 12 months.
- Remote or closer-to-home hearing tests are available for those living far away or with advanced cancer.
- Patients should expect to track any changes in hearing to help adjust treatment plans.